Drug-coated balloons reduced MACE and TLR compared to conventional angioplasty and showed no clinical differences versus drug-eluting stents in patients with in-stent restenosis.
Does drug-coated balloon reduce MACE/TLR compared to conventional angioplasty or drug-eluting stents in patients with in-stent coronary restenosis?
Drug-coated balloons are a reasonable alternative to repeat stenting with drug-eluting stents for the treatment of in-stent restenosis.
Absolute Event Rate: 0% vs 0%
In patients with ISR, DCB reduced MACE/TLR when compared with POBA. There were no clinical differences between DCB and DES even after inclusion of the SELUTION4ISR trial, thus suggesting that DCB are reasonable alternative to repeat stenting in patients presenting with ISR.
Maqsood et al. (Thu,) reported a other. Drug-coated balloons reduced MACE and TLR compared to conventional angioplasty and showed no clinical differences versus drug-eluting stents in patients with in-stent restenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: